Overcoming the legal and regulatory barriers to drug repurposing

Drug repurposing has been proposed as a strategy to develop new therapies that has fewer risks, lower costs and shorter timelines than developing completely new drugs. However, the potential of this strategy has not been as widely realized as hoped, in part owing to legal and regulatory barriers. Here, we highlight these barriers and consider how they could be overcome.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Repurposing metformin as a potential anticancer agent using in silico technique

• Mona Mahfauz
• , Ozel Yuruker
• & Rasime Kalkan

DARU Journal of Pharmaceutical Sciences Open Access 26 June 2024

Drug repurposing for cancer therapy

• Ying Xia
• , Ming Sun
• … Wei-Lin Jin

Signal Transduction and Targeted Therapy Open Access 19 April 2024

Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government

• Karel H. van der Pol
• , Mohamad Aljofan
• … Michael Spedding

Applied Health Economics and Health Policy Open Access 03 July 2023